The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review

Ying Sun, Weici Zhang, Baosen Li, Zhengsheng Zou, Carlo Selmi, M. Eric Gershwin

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Organ-specific and systemic autoimmune diseases share numerous features and often coexist in the same patient. Autoimmune cholangitis/primary biliary cirrhosis and Sjogren syndrome represent paradigmatic examples of the common grounds of different autoimmunity phenotypes based on similarities in clinical manifestations and immunopathogenesis. In fact, primary biliary cirrhosis and Sjogren’s syndrome have both been coined as an autoimmune epithelitis in which apoptosis may be in both cases the key element to explain the organ-specific immune-mediated injury against the biliary and exocrine gland epithelia, respectively. Further, growing evidence supports in both diseases the view that B cells, T cytotoxic cells, and T helper cells are involved in chronic inflammation, likely via the altered expression of pro-inflammatory cytokines. The presence of estrogen receptors on the biliary and exocrine gland epithelia has been advocated as a key to the female predominance encountered in primary biliary cirrhosis and Sjogren's syndrome. Sadly, despite available data, therapeutic approaches remain largely unsatisfactory and recent studies with mechanistic approaches (as in the case of B cell depletion with rituximab) have been of partial benefit only. Future studies should focus on new molecular tools (single-cell transcriptomics, microRNA, epigenetics) to provide unique insights into common mechanisms.

Original languageEnglish
Pages (from-to)301-315
Number of pages15
JournalClinical Reviews in Allergy and Immunology
Volume48
Issue number2-3
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Biliary Liver Cirrhosis
Sjogren's Syndrome
Exocrine Glands
B-Lymphocytes
Epithelium
Cholangitis
Helper-Inducer T-Lymphocytes
MicroRNAs
Autoimmunity
Epigenomics
Estrogen Receptors
Autoimmune Diseases
Apoptosis
Cytokines
Inflammation
Phenotype
Wounds and Injuries
Therapeutics

Keywords

  • Autoantibody
  • Cholestasis
  • Epithelitis
  • Sicca syndrome
  • Tolerance breakdown

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)

Cite this

The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis : A Comprehensive Review. / Sun, Ying; Zhang, Weici; Li, Baosen; Zou, Zhengsheng; Selmi, Carlo; Gershwin, M. Eric.

In: Clinical Reviews in Allergy and Immunology, Vol. 48, No. 2-3, 01.06.2015, p. 301-315.

Research output: Contribution to journalArticle

Sun, Ying ; Zhang, Weici ; Li, Baosen ; Zou, Zhengsheng ; Selmi, Carlo ; Gershwin, M. Eric. / The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis : A Comprehensive Review. In: Clinical Reviews in Allergy and Immunology. 2015 ; Vol. 48, No. 2-3. pp. 301-315.
@article{11c886222dae43f597608d42d9192a4f,
title = "The Coexistence of Sj{\"o}gren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review",
abstract = "Organ-specific and systemic autoimmune diseases share numerous features and often coexist in the same patient. Autoimmune cholangitis/primary biliary cirrhosis and Sjogren syndrome represent paradigmatic examples of the common grounds of different autoimmunity phenotypes based on similarities in clinical manifestations and immunopathogenesis. In fact, primary biliary cirrhosis and Sjogren’s syndrome have both been coined as an autoimmune epithelitis in which apoptosis may be in both cases the key element to explain the organ-specific immune-mediated injury against the biliary and exocrine gland epithelia, respectively. Further, growing evidence supports in both diseases the view that B cells, T cytotoxic cells, and T helper cells are involved in chronic inflammation, likely via the altered expression of pro-inflammatory cytokines. The presence of estrogen receptors on the biliary and exocrine gland epithelia has been advocated as a key to the female predominance encountered in primary biliary cirrhosis and Sjogren's syndrome. Sadly, despite available data, therapeutic approaches remain largely unsatisfactory and recent studies with mechanistic approaches (as in the case of B cell depletion with rituximab) have been of partial benefit only. Future studies should focus on new molecular tools (single-cell transcriptomics, microRNA, epigenetics) to provide unique insights into common mechanisms.",
keywords = "Autoantibody, Cholestasis, Epithelitis, Sicca syndrome, Tolerance breakdown",
author = "Ying Sun and Weici Zhang and Baosen Li and Zhengsheng Zou and Carlo Selmi and Gershwin, {M. Eric}",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s12016-015-8471-1",
language = "English",
volume = "48",
pages = "301--315",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2-3",

}

TY - JOUR

T1 - The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis

T2 - A Comprehensive Review

AU - Sun, Ying

AU - Zhang, Weici

AU - Li, Baosen

AU - Zou, Zhengsheng

AU - Selmi, Carlo

AU - Gershwin, M. Eric

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Organ-specific and systemic autoimmune diseases share numerous features and often coexist in the same patient. Autoimmune cholangitis/primary biliary cirrhosis and Sjogren syndrome represent paradigmatic examples of the common grounds of different autoimmunity phenotypes based on similarities in clinical manifestations and immunopathogenesis. In fact, primary biliary cirrhosis and Sjogren’s syndrome have both been coined as an autoimmune epithelitis in which apoptosis may be in both cases the key element to explain the organ-specific immune-mediated injury against the biliary and exocrine gland epithelia, respectively. Further, growing evidence supports in both diseases the view that B cells, T cytotoxic cells, and T helper cells are involved in chronic inflammation, likely via the altered expression of pro-inflammatory cytokines. The presence of estrogen receptors on the biliary and exocrine gland epithelia has been advocated as a key to the female predominance encountered in primary biliary cirrhosis and Sjogren's syndrome. Sadly, despite available data, therapeutic approaches remain largely unsatisfactory and recent studies with mechanistic approaches (as in the case of B cell depletion with rituximab) have been of partial benefit only. Future studies should focus on new molecular tools (single-cell transcriptomics, microRNA, epigenetics) to provide unique insights into common mechanisms.

AB - Organ-specific and systemic autoimmune diseases share numerous features and often coexist in the same patient. Autoimmune cholangitis/primary biliary cirrhosis and Sjogren syndrome represent paradigmatic examples of the common grounds of different autoimmunity phenotypes based on similarities in clinical manifestations and immunopathogenesis. In fact, primary biliary cirrhosis and Sjogren’s syndrome have both been coined as an autoimmune epithelitis in which apoptosis may be in both cases the key element to explain the organ-specific immune-mediated injury against the biliary and exocrine gland epithelia, respectively. Further, growing evidence supports in both diseases the view that B cells, T cytotoxic cells, and T helper cells are involved in chronic inflammation, likely via the altered expression of pro-inflammatory cytokines. The presence of estrogen receptors on the biliary and exocrine gland epithelia has been advocated as a key to the female predominance encountered in primary biliary cirrhosis and Sjogren's syndrome. Sadly, despite available data, therapeutic approaches remain largely unsatisfactory and recent studies with mechanistic approaches (as in the case of B cell depletion with rituximab) have been of partial benefit only. Future studies should focus on new molecular tools (single-cell transcriptomics, microRNA, epigenetics) to provide unique insights into common mechanisms.

KW - Autoantibody

KW - Cholestasis

KW - Epithelitis

KW - Sicca syndrome

KW - Tolerance breakdown

UR - http://www.scopus.com/inward/record.url?scp=84939997597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939997597&partnerID=8YFLogxK

U2 - 10.1007/s12016-015-8471-1

DO - 10.1007/s12016-015-8471-1

M3 - Article

C2 - 25682089

AN - SCOPUS:84939997597

VL - 48

SP - 301

EP - 315

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2-3

ER -